AdvanSix (ASIX) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 sales rose 6% year-over-year to $453–$453.5 million, driven by higher domestic nylon volumes, robust ammonium sulfate demand, and strong acetone pricing.
Net income for Q2 2024 was $38.9 million, up from $32.7 million in Q2 2023.
Adjusted EPS reached $1.55, a 24% increase year-over-year; Adjusted EBITDA was $78.1 million, up 19%.
Cash flow from operations improved to $50–$50.2 million, with free cash flow at $16.7–$17 million.
Returned $8 million to shareholders via dividends and repurchases in Q2 2024.
Financial highlights
Adjusted EBITDA margin improved to 17.2% from 15.4% year-over-year.
Q2 2024 diluted EPS was $1.43; gross margin was 17.9% (up from 15.9% YoY).
Capital expenditures increased to $33–$33.5 million, reflecting planned maintenance and growth investments.
Debt leverage at 1.8x as of Q2 2024, within the target range of 1x–2.5x.
Net debt increased to $217.9 million as of June 30, 2024.
Outlook and guidance
Higher ammonium sulfate pricing expected in Q3 2024 year-over-year, with robust demand and typical seasonality.
North American nylon industry spreads expected to modestly improve through 2024 due to tighter supply.
2024 capital expenditures projected at $140–$150 million, focused on maintenance, risk mitigation, and growth.
Planned plant turnarounds to impact pre-tax income by $38–$43 million in 2024.
SUSTAIN program targets ~70% granular conversion by year-end and full completion by 2027.
Latest events from AdvanSix
- Q4 sales up 9% with Plant Nutrients strength; 2026 focus on cost savings and cash flow.ASIX
Q4 202520 Feb 2026 - Diversified growth, strong sulfur nutrition demand, and disciplined capital strategy drive outlook.ASIX
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales up 23% to $398M; $12M USDA grant and Hopewell maintenance impact highlighted.ASIX
Q3 202417 Jan 2026 - FY24 net income was $44.1M on $1.52B sales; cash flow and 2025 outlook remain strong.ASIX
Q4 202423 Dec 2025 - Proxy covers director elections, auditor ratification, pay, ESG, and governance reforms.ASIX
Proxy Filing1 Dec 2025 - Proxy covers director elections, auditor, compensation, stock plan, and officer liability amendment.ASIX
Proxy Filing1 Dec 2025 - Board recommends all proxy proposals, including director elections and charter amendment.ASIX
Proxy Filing1 Dec 2025 - Updated voting rules clarify effects of abstentions and non-votes on all annual meeting proposals.ASIX
Proxy Filing1 Dec 2025 - Q1 2025 saw strong sales, profit rebound, and Plant Nutrients growth, aided by insurance proceeds.ASIX
Q1 202528 Nov 2025